mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0004 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0005 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.004 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |